Drug Database
Back to search

Netherlands· NL-65d29b419b14

Tookad 200 mg poeder voor oplossing voor injectie

A padeliporfin product containing padeliporfinedikalium, registered in Netherlands by Steba Biotech S.A.. The same ATC class is registered in 8 of our 19 countries.

ATC L01XD07

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedTookad 200 mg poeder voor oplossing v…ATCL01XD07REGISTER NO.NL-65d29b419b14PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about padeliporfinedikaliumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Padeliporfin is registered in 8 of 19 countries.

Countries holding a registration under ATC L01XD07 (padeliporfin), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 5 of them publish a price we can compare per daily dose
Search padeliporfin products by name

Padeliporfin · ATC L01XD07

8 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
PADELIPORFINEDIKALIUM
Manufacturer
Steba Biotech S.A.
Country
Netherlands (NL)
ATC code
L01XD07
ATC class
Padeliporfin
Defined daily dose
0.26 g, P
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/17/1228

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under L01XD07

Padeliporfin, as other registers publish it.

All padeliporfin products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ec9f7da6-7938-4b3a-b521-0b3f40b7db24
GET /v1/drugs/ec9f7da6-7938-4b3a-b521-0b3f40b7db24?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Poeder voor oplossing voor injectie",
  "route": "Intraveneus gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/tookad-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Padeliporfin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp118743",
  "excipients": [
    "MANNITOL (D-) (E 421)",
    "STIKSTOF (HEAD SPACE) (E 941)"
  ],
  "substances": [
    "PADELIPORFINEDIKALIUM"
  ],
  "leaflet_url": null,
  "authorised_at": "2017/11/10",
  "procedure_number": "EMEA/H/C/004182",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/17/1228",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about padeliporfin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console